Gilead Sciences said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases.
Trending
- Economic crisis in France goes beyond its overspending problem | Money News
- Trump warns firms on immigration law as detained South Koreans to go free | Migration News
- Unions warn government not to water down workers’ rights bill
- Supertramp co-founder and co-vocalist Rick Davies dies aged 81
- UK weather: Rain likely above average this autumn – but why it might not clear the drought | Science, Climate & Tech News
- Carlos Alcaraz dominates Jannik Sinner in US Open final to win 6th grand slam
- Germany bounce back with win vs. Northern Ireland – DW – 09/07/2025
- ‘God’s influencer’ declared first millennial saint – DW – 09/07/2025
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
By Reuters Econ
